Trials / Completed
CompletedNCT00797589
Effect of Prime Solution on Fluid Balance After Open Heart Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- University of Helsinki · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The use of Tetraspan® as prime solution can reduce fluid extravasation after perfusion versus Ringer acetate. Plasma-adapted HES-solutions produce also less acidosis.
Detailed description
Fifty patients scheduled for elective primary and single cardiac surgery include in this prospective study. Patients with preoperative coagulation disorders, or renal or hepatic failure, are excluded. Before admission to the operation theatre, the patients allocate in random order to receive one of the following solutions during the extracorporeal circulation: 1. Ringer-acetate solution 2. 6% HES solution (Tetraspan®) During the 1 postoperative day we register hemodynamic changes, fluid balance, fluid extravasation, plasma ion concentration, modified thromboelastography, and kidney function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HES | 20ml/kg as prime fluid |
| DRUG | Ringer lactate |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2008-11-25
- Last updated
- 2015-08-25
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00797589. Inclusion in this directory is not an endorsement.